Holdings (as at 2026-05-22)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
Organon & Co. 3.83%
Humana Inc. 3.79%
Elevance Health Inc. 2.88%
DaVita Inc. 2.75%
Solventum Corporation 2.51%
Exelixis, Inc. 2.49%
Molina Healthcare, Inc. 2.36%
The Cigna Group 2.29%
Biogen Inc. 2.26%
Incyte Corporation 2.20%
Bio-Rad Laboratories, Inc. (Class A) 2.20%
Globus Medical, Inc. (Class A) 2.10%
Cardinal Health, Inc. 2.03%
Zimmer Biomet Holdings, Inc. 2.02%
Chemed Corporation 1.98%
Universal Health Services, Inc. (Class B) 1.88%
Encompass Health Corporation 1.85%
HCA Healthcare, Inc. 1.78%
Regeneron Pharmaceuticals, Inc. 1.76%
Merck & Co., Inc. 1.74%
Ionis Pharmaceuticals, Inc. 1.72%
Masimo Corporation 1.71%
Penumbra, Inc. 1.71%
Amgen Inc. 1.65%
United Therapeutics Corporation 1.64%
Becton, Dickinson and Company 1.60%
Pfizer Inc. 1.57%
Tenet Healthcare Corporation 1.57%
QIAGEN N.V. 1.50%
Illumina, Inc. 1.50%
Revvity, Inc. 1.42%
Natera, Inc. 1.30%
Henry Schein, Inc. 1.29%
Quest Diagnostics Incorporated 1.27%
Bristol-Myers Squibb Company 1.25%
Steris Plc 1.25%
Labcorp Holdings Inc. 1.25%
UnitedHealth Group Incorporated 1.23%
Gilead Sciences, Inc. 1.23%
ResMed Inc. 1.18%
Certara, Inc. 1.18%
Medtronic Plc 1.16%
GE HealthCare Technologies Inc. 1.15%
The Cooper Companies, Inc. 1.12%
Insmed Incorporated 1.11%
Neurocrine Biosciences, Inc. 1.01%
Eli Lilly and Company 0.99%
Sarepta Therapeutics, Inc. 0.99%
Waters Corporation 0.98%
Halozyme Therapeutics, Inc. 0.90%
Agilent Technologies, Inc. 0.86%
IQVIA Holdings Inc. 0.84%
Johnson & Johnson 0.82%
BioMarin Pharmaceutical Inc. 0.82%
Align Technology, Inc. 0.81%
Thermo Fisher Scientific Inc. 0.78%
Medpace Holdings, Inc. 0.77%
Abbott Laboratories 0.73%
Medline Inc. (Class A) 0.71%
Zoetis Inc. 0.59%
West Pharmaceutical Services, Inc. 0.51%
DexCom, Inc. 0.46%
Royalty Pharma Plc (Class A) 0.46%
Sotera Health Company 0.44%
Edwards Lifesciences Corporation 0.43%
AbbVie Inc. 0.40%
Stryker Corporation 0.39%
Vertex Pharmaceuticals Incorporated 0.39%
IDEXX Laboratories, Inc. 0.39%
Intuitive Surgical, Inc. 0.38%
Viking Therapeutics, Inc. 0.38%
Boston Scientific Corporation 0.37%
Veeva Systems Inc. (Class A) 0.37%
Envista Holdings Corporation 0.37%
Danaher Corporation 0.36%
Alnylam Pharmaceuticals, Inc. 0.36%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.